The global celiac disease drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Celiac disease is an autoimmune disorder in which a protein called gluten damages the small intestine’s membrane. Gluten can be present in grains such as rye, barley, and wheat. Gluten causes an immunological reaction that damages the villi in the small intestine (small finger-like projections in the small intestine which promote absorption). The body’s ability to absorb proteins, nutrients, lipids, vitamins, carbs, and minerals is hampered by the damage. This eventually leads to malnutrition. It causes neurological malfunction, infertility, osteoporosis, and anemia if left untreated. Men and women of various ages and races are affected by celiac disease. HLA DQ2 and HLA DQ8 are two of the most critical genes linked to celiac disease. About 30% of the world’s population carries one or both genes, however, only one in every 30 people will acquire the condition. Screening and biopsy are used to diagnose the condition. It is estimated that 80% of celiac disease cases go undetected or are misdiagnosed as another disease.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/celiac-disease-drug-market
The key players operating in the global celiac disease drug market include Pfizer Inc., Johnson & Johnson Services, Inc., and Bristol-Myers Squibb Co., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in August 2020, Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease announced the initiation of the Phase 2b PROACTIVE (PROvention Amgen Celiac ProtecTIVE) study of PRV-015, an anti-interleukin-15 monoclonal antibody, in adult celiac patients not responding to a gluten-free diet, a condition known as ‘Non-Responsive Celiac Disease’ (NRCD). Moreover, in November 2019, Bristol-Myers Squibb Co., has announced the acquisition of Celgene Corporation, a company that works in celiac disease treatment. This acquisition expands the product portfolio for Bristol company.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Drugs
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Pfizer Inc., Johnson & Johnson Services, Inc., and Bristol-Myers Squibb Co., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Celiac Disease Drug Market Report by Segment
By Drugs
- First Line of Treatment
- Second Line of Treatment
A full report of Celiac Disease Drug Market is available at: https://www.omrglobal.com/industry-reports/celiac-disease-drug-market
Celiac Disease Drug Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Bristol-Myers Squibb Co.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
